Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed

The therapeutic approach with statins is widely used in the control of dyslipidemias. However, there is no laboratory evaluation to elect patients to make use of this class of therapeutic drugs. We analyzed the prevalence of anti-signal recognition particle (anti-SRP) and anti-3-hydroxy-3-methylglut...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Alzira Alves Siqueira, da Silva, Vinicius Gomes, Vieira, Thaiane Fagundes, Delgado, Pamela Oliveira, Corazini, Roseli, Feder, David, Fonseca, Fernando Luiz Affonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392535/
https://www.ncbi.nlm.nih.gov/pubmed/30170376
http://dx.doi.org/10.1097/MD.0000000000011858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392535/
https://www.ncbi.nlm.nih.gov/pubmed/30170376
http://dx.doi.org/10.1097/MD.0000000000011858

Ejemplares similares